On Wednesday, the Federal Circuit issued its decision in Amgen, Inc. v. Sandoz, Inc. The decision—mostly focused on the specifics of certain biosimilar production claims—also includes a brief discussion that illustrates one of the reasons that many of the patents issued by the USPTO create a chilling effect on public innovation.
Tag Archive for software patents
Innovation Is Alive And Well—R&D
by Josh Landau •
As part of Patent Progress’ series on innovation in the United States, we are examining ways to measure innovation. One useful metric, measuring the investment being made in the creation of new and innovative technologies, is research and development spending. This metric tends to show the investment in innovation, in particular by larger companies. And…
Multiple Petitions? More Like Multiplicative Claiming And Assertion
by Josh Landau •
One of the criticisms frequently leveled against inter partes reviews (IPRs) is that people file multiple IPRs; they file two, three, four IPR petitions in order to harass a patent owner. Complaints notwithstanding, the data shows just how infrequent a practice this is. The data also shows that the blame for the occasions when this…